Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Progenitor (PGEN) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (55)	3/20/1998 1:07:00 PM
From: scaram(o)uche	Respond to of 106

Steve: I'm a consultant. I sometimes need to get observations into the hands of clients first, and SI users second. I've also been doing some research regarding the potential of a kit for HH. Sorry for the delay. T7T7 played absolutely zero role in my thoughts about the company. I can say that the $51 million figure is just a tad of a stretch, in that it covers fees and milestones of $4.3 million for each of eleven products. Don't hold your breath. On the other hand, there are royalties and retained rights. I'd say that it should be simple to determine if the project is still alive at Chiron/Viagene. Rick